Nasdaq · CIK 0001946563
SXTP 60 DEGREES PHARMACEUTICALS, INC.
Insider trading from SEC Form 4. Last filing Jun 15, 2026. Close $0.96 on Oct 9, 2026, +14% from the 52-week low and -87% from the high.
In brief
60 DEGREES PHARMACEUTICALS, INC. (SXTP) has 15 SEC Form 4 filings on file from 4 insiders, the latest filed on Jun 15, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
7 open-market trades have been scored at SXTP. The newest: Geoffrey S Dow (President and CEO) bought $10k of stock on Jun 12, 2026, filed Jun 15, 2026, scored 49 (moderate). The largest of the 7 shown: Geoffrey S Dow (President and CEO) bought $90k on Dec 5, 2024, scored 57 (moderate). 2 insiders bought within 14 days of each other around Dec 12, 2024.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at 60 DEGREES PHARMACEUTICALS, INC., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 49Moderate | Geoffrey S Dow President and CEO buy | $10k 7,350 shares | +44% | 0% from low-87% from high | |
| 51Moderate | Geoffrey S Dow President and CEO buy | $7,759 9,670 shares | +19% | 0% from low-89% from high | |
| 49Moderate | Geoffrey S Dow President and CEO buy | $12k 12,963 shares | +35% | +3% from low-91% from high | |
| 29Weak | Cheryl Xu director buy | $14k 5,000 shares | +46% | +99% from low-74% from high | |
| 29Weak | Cheryl Xu director buy | $21k 13,000 shares | +32% | - | |
| 57Moderate | Geoffrey S Dow President and CEO buy | $90k 73,951 shares | +358% | - | |
| 35Weak | Geoffrey S Dow President and CEO buy | $6,367 7,000 shares | +51% | - |
Transactions
Every row filed, 27 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | Geoffrey S Dow President and CEO | POpen-market purchase Common Stock | +7,350 | $1.38 | $10k | 24,131 | Jun 15, 2026 |
| Dec 15, 2025 | Geoffrey S Dow President and CEO | POpen-market purchase Common Stock | +9,670 | $0.80 | $7,759 | 59,618 | Dec 16, 2025 |
| Dec 10, 2025 | Geoffrey S Dow President and CEO | POpen-market purchase Common Stock | +9,350 | $0.95 | $8,886 | 46,335 | Dec 12, 2025 |
| Dec 11, 2025 | Geoffrey S Dow President and CEO | POpen-market purchase Common Stock | +3,613 | $0.92 | $3,318 | 49,948 | Dec 12, 2025 |
| Sep 12, 2025 | Geoffrey S Dow President and CEO | AGrant or award Common Stock | +7,201 | $1.39 | $9,996 | 33,372 | Sep 15, 2025 |
| Sep 26, 2024 | Kristen Landon Chief Operating Officer | AGrant or award Stock Options (Right to Buy)derivative | +4,167 | $0.00 | $0 | 4,167 | Aug 14, 2025 |
| Jan 17, 2025 | Kristen Landon Chief Operating Officer | AGrant or award Common Stock | +4,540 | $0.00 | $0 | 4,540 | Aug 14, 2025 |
| Jun 9, 2025 | Geoffrey S Dow President and CEO | AGrant or award Common Stock | +4,376 | $2.99 | $13k | 26,171 | Jun 9, 2025 |
| Jun 3, 2025 | Cheryl Xu director | POpen-market purchase Common Stock | +3,000 | $2.87 | $8,610 | 13,816 | Jun 5, 2025 |
| Jun 3, 2025 | Cheryl Xu director | POpen-market purchase Common Stock | +2,000 | $2.90 | $5,800 | 15,816 | Jun 5, 2025 |
| Jan 2, 2025 | Tyrone Miller CFO | AGrant or award Stock Option (Right to Buy)derivative | +75,000 | $0.00 | $0 | 75,000 | Jan 24, 2025 |
| Jan 2, 2025 | Geoffrey S Dow President and CEO | AGrant or award Stock Option (Right to Buy)derivative | +525,000 | $0.00 | $0 | 525,000 | Jan 24, 2025 |
| Jan 17, 2025 | Tyrone Miller CFO | AGrant or award Common Stock | +11,626 | $0.00 | $0 | 26,370 | Jan 21, 2025 |
| Jan 17, 2025 | Geoffrey S Dow President and CEO | AGrant or award Common Stock | +14,394 | $0.00 | $0 | 108,974 | Jan 21, 2025 |
| Dec 12, 2024 | Cheryl Xu director | POpen-market purchase Common Stock | +2,500 | $1.85 | $4,625 | 43,578 | Dec 18, 2024 |
| Dec 12, 2024 | Cheryl Xu director | POpen-market purchase Common Stock | +2,500 | $1.80 | $4,500 | 46,078 | Dec 18, 2024 |
| Dec 13, 2024 | Cheryl Xu director | POpen-market purchase Common Stock | +1,500 | $1.60 | $2,400 | 47,578 | Dec 18, 2024 |
| Dec 13, 2024 | Cheryl Xu director | POpen-market purchase Common Stock | +1,500 | $1.58 | $2,370 | 49,078 | Dec 18, 2024 |
| Dec 13, 2024 | Cheryl Xu director | POpen-market purchase Common Stock | +1,500 | $1.55 | $2,325 | 50,578 | Dec 18, 2024 |
| Dec 13, 2024 | Cheryl Xu director | POpen-market purchase Common Stock | +1,500 | $1.52 | $2,280 | 52,078 | Dec 18, 2024 |
| Dec 16, 2024 | Cheryl Xu director | POpen-market purchase Common Stock | +2,000 | $1.45 | $2,900 | 54,078 | Dec 18, 2024 |
| Dec 5, 2024 | Geoffrey S Dow President and CEO | POpen-market purchase Common Stock | +17,549 | $1.11 | $20k | 38,178 | Dec 9, 2024 |
| Dec 6, 2024 | Geoffrey S Dow President and CEO | POpen-market purchase Common Stock | +20,579 | $1.20 | $25k | 58,757 | Dec 9, 2024 |
| Dec 9, 2024 | Geoffrey S Dow President and CEO | POpen-market purchase Common Stock | +35,823 | $1.27 | $46k | 94,580 | Dec 9, 2024 |
| Nov 19, 2024 | Geoffrey S Dow President and CEO | POpen-market purchase Common Stock | +2,500 | $0.90 | $2,248 | 16,129 | Nov 21, 2024 |
| Nov 20, 2024 | Geoffrey S Dow President and CEO | POpen-market purchase Common Stock | +1,000 | $0.92 | $924 | 17,129 | Nov 21, 2024 |
| Nov 21, 2024 | Geoffrey S Dow President and CEO | POpen-market purchase Common Stock | +3,500 | $0.91 | $3,195 | 20,629 | Nov 21, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Geoffrey S DowPresident and CEO
- Kristen LandonChief Operating Officer
- Tyrone MillerCFO
- Cheryl Xudirector
Questions about SXTP
Answered from the filings on this page, as of the latest one.
Are insiders buying SXTP?
No. In the last 90 days no insider at 60 DEGREES PHARMACEUTICALS, INC. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade SXTP on the open market?
Geoffrey S Dow (President and CEO) bought $10k of SXTP on Jun 12, 2026 and filed the Form 4 on Jun 15, 2026. InsiderTell scored 49 (moderate).
How many insiders file Form 4 at 60 DEGREES PHARMACEUTICALS, INC.?
4 people have filed a Form 4 at 60 DEGREES PHARMACEUTICALS, INC., among them Geoffrey S Dow (President and CEO), Kristen Landon (Chief Operating Officer), Tyrone Miller (CFO). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.